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Abbreviations: 
ADI: Acceptable daily intake 
BBP: Butylbenzylphthalate 
DEHP: Di(ethylhexyl)phthalate 
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GABA: Gamma-aminobutyric acid 
GC: Gas chromatography 
HILIC: Hydrophilic (ion) interaction liquid chromatography 
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LDA: Linear discriminant analysis 
LDL: Low density lipoprotein 
MS: Mass spectrometry 
NMR: Nuclear magnetic resonance 
NOAEL: No observed adverse effect level 
OPLS: Orthogonal projection to latent structure 
PAHs: Polycyclic aromatic hydrocarbons 
PCA: Principal component analysis 
PLS: Partial least squares 
PLS-DA: Partial least squares discriminant analysis 
SVM: Support vector machines 
TCA: Tricarboxylic acid 
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Abstract 
Human beings may be exposed via their environment to multiple chemicals as a consequence 
of human activities and the use of man made products. Little knowledge is routinely generated 
on the hazards of these chemical mixtures. The metabolomic approach is widely used to 
identify metabolic pathways modified by diseases, drugs, or toxic exposures. This review, 
based on the state-of-the-art of the current applications of metabolomics in environmental 
health, attempts to determine whethermetabolomics can constitute an original approach to the 
study of associations between multiple, low-dose environmental exposure and subtoxic effects 
in human beings.Studying the biochemical consequences of complex environmental 
exposures is a challenge demanding the development of careful experimental and 
epidemiological designs, in order to take into account possible confounders associated with 
the high level of inter-individual variability induced by different lifestyles. The choice of 
populations studied, sampling and storage procedures, statistical tools used and system 
biology are worthy of consideration. Suggestions for improved experimental and 
epidemiological designs are discussed. This short review shows that metabolomics may be a 
powerful tool in environmental health in the identification of both complex exposure 
biomarkers directly in human populations and modified metabolic pathways, in a bid to 
improve understanding the environmental causes of diseases. Nevertheless, the validity of 
biomarkers and the relevancy of animal-to-human extrapolation remain key challenges that 
need to be properly explored.  
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Introduction 
Regulations on chemicals entering the European Union market, for both domestic and 
professional uses, are based on risk assessment and management,on a chemical-by-chemical 
basis (i.e. Regulations EC 1107/2009 on pesticides or EC 1907/2006 on chemicals). Although 
these methods allow a comprehensive risk assessment for single chemicals for regulatory 
purposes, they do not permit a global risk analysis in case of different uses and multiple 
exposures. Such multiple exposures are characterized by various substancesand sources or 
routes of exposure (diet, air, oral or respiratory for example). Regulatory toxicological 
toolsare not suitable to the study of effects induced by the complex and low-dose mixtures 
that arerepresentative of human exposures, and are of limited relevance for environmental 
health.In this context, the development of new strategies - especially the identification of 
biomarkersof early effect using high-throughput approachessuch as metabolomics - is of 
particular importance. This bioanalytical approach entails studying the nature and quantity of 
potentially all metabolites produced by an organism,i.e. the detectable endogenous molecules 
involved in the growth and homeostasis of the organism. Themetabolic profile constitutes the 
ultimate step in the cellular response, and is considered the key link between genesand 
phenotypes(Fiehn 2002).It has come to be widely used in recent years to identify metabolic 
pathways modified by disease, drugs or toxic exposure, as reviewed by several 
authors(Lindon et al. 2004;Robertson et al. 2011). Because it has the ability to provide helpful 
information in the definition of markers of toxicity - as reported for example for 
hepatotoxicity or nephrotoxicity (Beger et al. 2010) - this approach may constitute an 
integrative tool to increase our understanding of the subtle metabolic disruptions induced by 
complex and low-dose exposures to pollutants as described in figure 1.  
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Furthermore, the metabolic changes induced by these exposures may be observed directly 
from biological fluidsthat are easy to collect - such as urine or blood - making possible their 
identification directly in humans. However, these changesremain difficult to highlight,due to 
the high number of potentially confoundingfactors affecting the metabolome, in addition to 
environmental exposure (lifestyle, diet or therapeutic drug treatments for example). This is 
why the metabolomic approach in humans has not yet been extensively explored in the field 
of environmental health. In this context, this short review attempts to determine whether 
metabolomics can constitute an original approach to study of the associations between 
multiple, low-dose exposures to environmental pollutants and effects in human 
beings.Following a short description of the methods used in metabolomics, current 
applications in environmental health – in both toxicology and epidemiology – will be 
describedto identify the most important criteria that would be taken into account.Finally, this 
article addresses ways to identify key methodological challenges. This article is not intended 
to be a comprehensive review of the methods used in metabolomics (already available 
elsewhere), nor to indicate how toxicological studies may provide a corroborative evidence to 
support the results observed in epidemiological studies. 
 
Methods used in metabolomics 
Metabolomics combines the use of analytical and statistical toolstoidentify the metabolites 
that are significantly modified between groupsas shown in the flowchart presented in figure 2. 
Two types of metabolomicapproaches can be distinguished: untargeted metabolomics, which 
corresponds to a comprehensive analysis of all measurable molecules in a sample (including 
unknown metabolites), and targetedmetabolomics, in whicha set of chemically and 
biochemically characterized metabolites (such as lipids, amino acids, nucleotides, or 
steroids)are measured.Samples used for metabolomic studies could be any biological matrices 
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(fluids such as urine, plasma, saliva, sperm, animal tissue extracts or human tissues like 
biopsies or placenta, for example). The most widely usedsamples are urine and plasma 
because theycorrespond tonon- (or minimally) invasive procedures and requirelimited, if 
any,pre-treatment steps, prior toanalysis. 
Analytical Tools 
The analytical tools used in metabolomics are based on spectroscopic techniques. Currently, 
due to their performance for the analysis of small organic molecules and their complementary 
information, nuclear magnetic resonance (NMR) and mass spectrometry(MS) are the most 
widely used analytical techniques in metabolomics. MSis mostly used in hyphenation with 
different chromatography techniques (gas or high/ultra-performanceliquid chromatography, 
respectively GC and H/UPLC) or capillary electrophoresisfor sample separation prior to MS 
analysis. Thesemethods have been in use formore than 40 years e.g. forthe characterization of 
cellular energy metabolism or forbiofluids analyses.Sample preparation steps typically used 
for NMR and MS analyses have recentlybeen reviewed (Alvarez-Sanchez et al. 2010a). The 
main advantagesof NMR rely on the ease of sample preparation, non-destructive analysis of 
the sample (which may be recovered for further analyses), adaptability of the method to high-
throughput analyses and the ability to provide a quantitative picture of the metabolic 
fingerprint. This technique wastherefore generally preferred for large-scale applications, 
where thousands of molecules were being measured within a short period of time. NMR 
allows for measurement of metabolites, typically at the μg/mL level, and is less sensitive than 
MSwhich can detect compounds at the pg/mL level. Besides sensitivity, the broaddiversity of 
ionization methods and mass analyzers(Bedair and Sumner 2008), available for MS allows 
identification of a large number of metabolites. The development of high-resolution MS 
techniques (particularly during the last ten years) has expanded the capacity for compound 
identification, thanks in particular to accurate mass measurements offering access to the 
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elemental composition of metabolites (and their potential fragments). This feature provides 
invaluable information for the identification of “known unknowns” using chemical database 
queries. However, unlike NMR, MS sensitivity is compound-dependent and may be affected 
by matrix effects. Moreover,absolute quantification by MS requires specific approaches based 
on targeted compounds, and global profiling is often limited to semi-quantitative approaches. 
To a lesser extent,optical spectroscopy (e.g. near-infrared or Raman) is also used because of 
the simplicity of sample preparation. Each toolcan provide complementary information 
regarding the wide diversity of metabolite chemical structures.Comprehensive reviews on 
these topics are available elsewhere(Bothwell and Griffin 2011;Dettmer et al. 2007;Dunn et 
al. 2005;Lindon and Nicholson 2008;Ross et al. 2007) and a comparison of NMR and MS 
techniques was recently covered as part of a toxicometabolomics review (Bouhifd et al. 
2013). 
Data pre-processing 
The objective of the data pre-processing stage is the achievement of extracted data 
corresponding to quantified spectral peaks, by converting raw data into files easily useable for 
statistical analyses. It includes different steps depending on the chosen analytical tool and has 
already been described well in the review by Madsen et al. (Madsen et al. 2010). Alignment, 
baseline correction, peak picking ordeconvolutionare several methods practicable for both MS 
and NMR techniques, and previously described (Koek et al. 2011;Theodoridis et al. 2012).In 
MS, resulting datasets include retention time, m/z ratio and intensity of each detected signal. 
Peak identification is therefore required.Normalization can also be used to minimize bias and 
experimental variability induced in the analytical step. In NMR spectroscopy,it is also 
possible to includeabucketing step in the case of untargeted metabolomics, where spectra are 
reduced into consecutive spectral bins(see Ross et al. 2007 for review).Subsequent steps 
include scaling - when maximum variance projection methods were applied -to give the same 
9 
 
weight to variables which could have different ranges. Most often, unit variance (the data 
matrix is divided by the standard deviation to obtain a variance of 1), mean centering 
(subtraction of the mean) or Pareto scaling (divided by the square root of the standard 
deviation) is used (see Van den Berg et al. 2006 for more information).The pre-processing 
steps were recently described in a comprehensive review (Molinska et al. 2012). Finally, 
filtering could also be used to improve data quality. A few techniques and practical examples 
are described in the review from Bouhifd (Bouhifd et al. 2013). 
Statistical tools 
Spectral analyses engender hundreds of variables (peaks or spectral regions) which are highly 
correlated. Dimension reduction is therefore one of the main objectives of statistical analyses 
and is performed by multivariate methods.A large number of different statistical tools are 
available – in both unsupervised and supervised methods – and has been briefly described 
elsewhere (Madsen et al. 2010; Putri et al. 2013). For example, we canmentionprincipal 
component analysis (PCA), non-hierarchical or hierarchical clustering,linear discriminant 
analysis (LDA), partial least squares (PLS) regressions, orthogonal projections to latent 
structures (OPLS), and machine learning techniques such as support vector machines (SVM). 
PCA and PLS are most often used to study the effects of environmental pollutants on health 
(see next chapter).  
PCA is a non-supervised method allowings visualization of the spontaneous distribution of 
the observation in a two dimensional plane(Bair et al. 2006);Partial least squares (PLS) 
regressions are supervised methods that supply a statistical model explaining individual 
characteristics (e.g. exposures) according to the matrix of experimental variables (i.e. 
metabolites)(Wold et al. 2001). Different variants exist, such as PLS-DA(PLS-discriminant 
analysis), widely used for modeling observations belonging to different groups (e.g. 
case/control or differently exposed individuals)(Waterman et al. 2009) or orthogonal PLS 
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(OPLS). In OPLS, Y-predictive variability of X (correlated to Y) is separated from Y-
orthogonal variability (uncorrelated to Y). Predictive variability is only modeled by predictive 
components(Trygg and Wold 2002). In all cases, the different models built should be 
validated. The most common methods are the use of an independent validation set or cross-
validation. A description of these methods is made elsewhere (Broadhurst and Kell 
2006;Wold et al. 2001). 
Metabolite identification and biological interpretation 
Metabolite identification plays a key role in the interpretation of the metabolomics research 
results. Different approaches are needed depending on the analytical tool chosen butspectral 
library searching on the Internet is a common step. For example, the Madison metabolic 
consortium database (MMCD, http://mmcd.nmrfam.wisc.edu/), the Human Metabolome 
Database (HMDB, http://www.hmdb.ca/), the Biological Magnetic Resonance Data Bank 
(BMRB, http://www.bmrb.wisc.edu/metabolomics/)and the Kyoto encyclopedia of genes and 
genomes (KEGG, http://www.genome.jp/kegg/) are widely used.Werner et al. (2008) 
reviewed databases from mass spectrometry data used for metabolome annotation.More 
recently, other authors have reviewed the huge development of the metabolome databases 
(Fukushima and Kusano, 2013), especially the HMDB which has been considerably 
expanded,and includes now more than 40,000 annotated metabolites (Whisart et al. 2009; 
2013). 
Unknown metabolites have to be identified using MS/MS or NMR structural characterization 
tools.When a chemical structure is suggested, confirmation can be obtained by comparison 
with the spectra of authentic standards.When potential metabolites from exogenous 
contaminants are suggested, it is also possible to carry out short experimentations in 
laboratory mammals exposed to the parent compounds, so asto unambiguously characterize 
their metabolites by plasma or urinary analysis (Jamin et al. 2013). 
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Two dimensional NMR spectra are also required as an aid to spectral assignment and to 
confirm the identity of metabolites.Once candidate biomarkers have been identified, the final 
step is to decipher the main metabolic pathways involved in the modifications observed, and 
suggest biological hypotheses in accordance with the involvement of the modified metabolites 
in biochemical pathways (amino-acids synthesis, energetic metabolism, fatty acids oxidation, 
etc.).  
In order to fully integrate these data, mechanistic interpretation has to be achieved at the 
metabolic network level. Metabolic network gathers all the metabolic reactions an organism 
can perform into a single mathematical model. For Humans, a compartmentalised model 
publicly available (Duarte et al. 2007) contains 3311 reactions and 2766 metabolites. The aim 
is to computationally decipher, among all these reactions and metabolites, the ones involved 
in the metabolic response of the organism when exposed to contaminants. To do so, 
algorithms have been developed which extract relevant sub-networks based on network 
topology and biomarkers (Jourdan et al. 2010). 
 
Current applications in environmental health 
Animal experiments and epidemiological studies are commonly used to assess potential 
factors that can affect human health, and in particular the effect of chemical exposure as a risk 
factor. In this context, comparing various exposure groups in animals or humanscan 
determine potential links between an environmental factor and a health effect. In the field of 
toxicology, metabolomics is used to identify candidate biomarkers of exposure and effects. 
Many toxicological studies demonstrate that metabolomics is a powerful method for detecting 
changes in the metabolome of exposed individuals. The identification of discriminant 
metabolites between groups is made easier by the possibility of controlled conditions: inter-
individual variability among tested animals is reduced by the use of similar species, strains, 
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individuals and laboratory conditions.Most of the toxicological studies have been published 
within the context of drug development(Beger et al. 2010;Robertson 2005). In recent years, 
some authors have focused on environmental pollutants, in particular endocrine disruptors 
such as phthalates (plasticizers widely found in our environment) and pesticides. Table 1 
describes the main studies carried out on animal models, the methodological approaches used, 
and the main results. Sumner et al. (2009) showed correlations between developmental 
outcomes in rat pups exposed to benzylbutylphthalate (BBP) during pregnancy and 
modification of the metabolic pathways in dams and pups. Modifications included metabolites 
derived from citrate cycle and amino acid catabolism. Changes were observed in urine by 
NMR spectroscopy and subsequent PCA and PLS-DA analyses. It has been suggested that 
di(ethylhexyl)phthalate (DEHP) exposure could modify several aminoacid concentrations 
(glutamine, valine, tyrosine/phenylalanine, isoleucine) in the plasma and liver extracts 
frommale mice (NMR analyses, OPLS statistical data treatment), leading the authors to 
suggest a new hepatic pathway targeted by DEHP exposure in mice explaining its potential 
for endocrine disruption (Eveillard et al. 2009). In utero,DEHP was also shown to affect lipid 
profiling in the fetal rat brain (Xu et al., 2007), which may lead to aberrant neurodevelopment. 
More recently, Xia and co-workers (2011) combined the analyses of multiple biological 
matrices, including maternal serum, placenta and fetal brain tissue in order to evaluate the 
teratogenic effects of di-n-butylphthalate (DBP) in mice. By means ofGC time-of-flight MS 
combined with PLS-DA, these authors have shown that DBP disrupted maternal and fetal 
metabolic profiles, altering citrate cycle, amino acid, purine and lipid metabolism.Van 
Ravenzwaay et al. (2010) used metabolomics based on MS analyses of plasma samples to 
investigate possible interactions resulting from combined exposure to DEHP and DBP in rats. 
They showed that simultaneous exposure to high dosages of the mixture (3mg/kg feed) over a 
period of 28 days resulted in a profile that was significantly different from the individual 
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compounds. However, these effects were less than additive and inconsistent changes were 
observed at lower doses. Co-exposure to DEHP and aroclor 1254 was found to disturb lipid 
metabolism, leading to an accumulation of lipid in the liver(Zhang et al. 2012). Tryptophan 
and phenylalanine metabolisms were also disturbed in this case. Recently, Cabaton et al. 
(2013) hypothesized that the metabolism of mice perinatally exposed to bisphenol A may be 
disrupted. After subcutaneous low-dose exposure (0.025 to 25 μg/kg BW/day) to pregnant 
mice from gestational day 8 through day 16 of lactation, they showed a disruption in the 
glycolysis, glycogenesis and energy metabolism both at postnatal day 2 and 21.They also 
confirmed brain development alterations suggested in the literature for bisphenol A(decrease 
in glutamate and GABA concentrations in brain samples at postnatal day 21) (Cabaton et al. 
2013). 
Some publications draw attention to the potential of metabolomics in pesticide research, 
including toxicological issues (see Aliferis and Chrysayi-Tokousbalides 2011 for review). 
They show promising results in terms of (eco)-toxicological risk assessment of bioactive 
compounds using model organisms representative of different levels of organization. Kim and 
co-workers investigated the metabolic profile of methoxychlor, an organochlorine insecticide 
known to be an endocrine disrupter. The NMR analyses of urine samples from female rats 
showed a decrease of acetate, benzoate, lactate, glycine and alanine in a dose-dependent 
manner(Kim et al. 2009).A recent study showed the impact of endosulfan, another 
organochlorine insecticide, on the metabolic profile of blood, bone marrow and liver in mice 
orally exposed for 11 weeks to a level corresponding to the acceptable daily intake (ADI). A 
decrease in plasma LDL, VLDL and choline concentrations and an increase in plasma glucose 
levels were observed, associated with a potential oxidative disturbance in the liver (Canlet et 
al. 2013). 
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The same team also showed modification of amino acid metabolism, citrate cycle, urea cycle 
and glucose metabolism in mice orally exposedto the same dose of endosulfan combined with 
atrazine and chlorpyrifos (exposure levels corresponding to their respective ADI).Wang and 
co-workers (2009, 2011) investigated the metabolic profiles of rats following exposure to 
chlorpyrifos and carbaryl, two anticholinesterase insecticides known to be neurotoxic in 
mammals. Serum analyses suggest that their exposure(alone or in combination) could cause a 
disturbance in energy and fatty acid metabolism in the liver mitochondria (Wang et al. 2009). 
Metabolomic analysis of urine confirmed these conclusions, especially in terms of impact on 
the energy metabolism (Wang et al. 2011). The same group recently investigated the 
metabolomic responses of rat to propoxur, another anticholinesterase insecticide (Liang et al. 
2012a; 2012b). The NMR analysis of urine samples suggeststhe induction of oxidative stress, 
and alteration inthe energy metabolism and lipid metabolism (enhancement of ketogenesis 
and fatty acid beta-oxidation) in the liver contributing to the hepatotoxicity of this insecticide, 
as previously shown for chlorpyrifos and carbaryl (Wang et al. 2009; 2011). They also studied 
the effect of combined exposures to oganophosphorus insecticides (dichlorvos or propoxur) 
with pyrethrinoïds (deltamethrin or permethrin), and showed that, even at doses not exhibiting 
any clinical or physiopathological effects, organophosphorus and pyrethrinoids, tested 
individually or in combination, were able to disrupt the energy metabolism of the liver 
andinduce potential nephrotoxicity (Wang et al. 2013; Liang et al. 2012c). Similar findings 
were published after oral and chronic exposures (drinking water) to dichlorvos in rats 
(disturbances in the carbohydrate and fatty acid metabolism, anti-oxidant system) (Yang et al. 
2011; 2013). Other authors investigated the metabolic changes in rats induced by chronic oral 
exposure (viadrinking water) to dimethoate, an organophosphorus insecticide. They found 
significant changes in the urinary and plasmatic metabolic UPLC-MS fingerprints, especially 
for L-tyrosine, citric, uric and suberic acids, glycylproline, allantoin, isovalerylglutamic acid 
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and lipids (as well as urinary organophosphorous metabolites). The authors suggested a link 
between these changes and the impairment of the hepatic and nervous systems (Feng et al. 
2012). A series of other chronic studies in rats on organophosphorus insecticides also showed 
renal and perturbed glucose, nucleic acid, and protein metabolism (for acephate) (Hao et al. 
2012), disturbance in energy and lipid metabalolism, oxidative stress, and DNA damage (for 
phorate) (X. Sun et al. 2012).This series of studies demonstratesthe ability of the 
metabolomics approach to identify metabolic pathways modified by environmental 
contaminants and suggest hypotheses about their potential mechanism of action. Moreover, as 
was observed for BBP, DBPand some organophosphorus pesticides, metabolomics could, in 
some cases, be more sensitive on a dose scale than histopathology orclinical blood 
biochemistry in recognizing early toxicological events. 
Recently, several other contaminants were investigated in rodents. Neerathilingam et al. 
(2010) showed a disturbance of the energy metabolism with changes in citrate cycle 
metabolites in 24-hour urine collection of rats exposed to tributylphosphate (an 
organophosphorous widely used as a solvent, extractant or plasticizer). The adverse renal 
response to perfluorododecanoic acid, a perfluorinated carboxylic chemical, was also 
identified in male rats as contributing to disorders in glucose and amino acid metabolism(H. 
Zhang et al. 2011).A modification of the urinary profile of mice subchronically exposed to 
benzene was described, even at a dose which does not elicit changes in body weight or blood 
parameters (R. Sun et al. 2012). Changes related to glutathione, TCA cycle and amino acids 
metabolism were observed in the urinary profile of rats exposed to acrylamide (J. Sun et al. 
2010). 
 
These publications indicate that metabolomics represents a promising tool for studying 
contaminant toxicity and mode of action, as well as for investigating the effects of mixtures of 
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xenobiotics. Nevertheless, in the case of environmental applications, most toxicological 
studies suffer from a lack of similarities with human exposure conditions, in particular 
through the use of high doses of a single chemical or simple mixture.Few low-dose studies are 
available in the case of chemical mixtures. For instance, Du et al. investigated the effect of a 
mixture of low-doses (corresponding to the NOAEL in a two-year study) of 4 
organophosphorus pesticides (dichlorvos, dimethoate, acephate and phorate). They showed 
disturbance in energy and lipid metabolism, oxidative stress, and DNA damage (Du et al. 
2013). Mehri et al. investigated the effect in mice of a mixture of low-doses (derived from 
their respective acceptable daily intakes) of six pesticides frequently found in fruits and 
vegetables grown in France and showed a metabolic signature linked to oxidative stress and 
glucose regulation (Merhi et al. 2010). Likewise, the metabolic dysfunction of contaminated 
lake water, which is an important drinking water source for the nearby city (in China)was 
investigated inmale mice. The water contamination includes polycyclic aromatic 
hydrocarbons (PAHs) and organochlorine insecticides. The study found that its ingestion 
induced liver damage with alterations in energy and amino acid metabolism(Y. Zhang et al. 
2011). 
Besides this metabolic profiling obtained in urine, plasma or tissue extracts from mammals 
exposed either orally or subcutaneously, more mechanistic studies are implemented on cell 
lines, both in animals (for example, neuronal cultures exposed to methylmercury and mercury 
chloride) (van Vliet et al. 2008) and in humans (for example, lung epithelial cells exposed to 
cigarette smoke or hepatocellular carcinoma-derived cells exposed to ammonia) (Vulimiri et 
al. 2009; Shintu et al. 2012).  
Given the limitations of experimental toxicology, the best strategy for the identification of 
metabolic disturbance in environmental health will be to set up studies directly targeted on the 
human populations. Most metabolomics studies carried out in humans focus on clinical 
17 
 
research and the identification of biomarkers for early detection in pathologies such as cancer, 
heart disease or adverse pregnancy outcomes(Diaz et al. 2011;Kenny et al. 2008;Mamas et al. 
2011; Kim et al. 2010). These studies are based on the comparison of a small number of 
people affected by the disease againsthealthy individuals. They are very promising in terms of 
the discovery of biomarkers to aid disease diagnosis, because predetermined pathologies have 
a major influence on the metabolic pathway of an organism, facilitating identification of 
discriminant metabolites between cases and controls. Environmental epidemiology aims at 
finding subtle metabolic disturbances resulting from chronic low-level exposure to multiple 
pollutants. Metabolomics is not very developed in this field of research because metabolic 
modifications expected with environmental exposures are thought to be minor in 
comparisonwith the inter-individual variability that can be observed in a human population. 
To our knowledge, only four studies have taken an interest in modification in urinary or blood 
metabolic profiles associated with human environmental exposures. The first of these 
concerned 51 workers exposed to welding fumes in Taiwan. The study has shown an increase 
of metabolites involved in inflammatory and oxidative tissue injury processes, especially 
glycine, taurine and betaine (Kuo et al. 2012). The second was interested in urinary metabolic 
profiles in 178 human volunteers living near a source of environmental cadmium pollution in 
Great Britain. Several metabolites involved in mitochondrial metabolism (citrate, 3-
hydroxyisovalerate and 4-deoxy-erythronic acid) and amino acid metabolism 
(dimethylgycine, creatine and creatinine) were associated with cadmium exposure, suggesting 
oxidative stress that was confirmed by an increase ofurinary 8-oxo-deoxyguanosine(Ellis et 
al. 2012). The third focused on 83 pregnant women living in a French agricultural area 
(Brittany). As a surrogate of environmental pesticide exposure, the surface area of land 
dedicated to agricultural cereal activities in their towns of residence was used to categorize 
the women into three groups. The study showed modifications to the urinary metabolites 
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involved in oxidative stress and energy metabolism (an increase in glycine, threonine, lactate 
and glycerophosphocholine and a decrease in citrate) in the most exposed women after 
adjusting for the main potential confounders (age, body mass index, parity and smoking) 
(Bonvallot et al. 2013). The largestof these studies was a large-scale epidemiological study 
(includingmore than 4,000 individuals),which was conducted to investigate metabolic 
variations within four different population groups with different dietary patterns (Asian, 
North-American, and European). The urinary metabolic excretion patterns were discriminated 
between populations having contrasting lifestyles, diets and pathology risk factors, in 
particular blood pressure and cardiovascular disease (Holmes et al. 2008). Such a large-scale 
metabolic approach could be very useful in identifying the main interactions between 
lifestyle, diet, genetics and environmental exposures.  
 
Discussion 
Metabolomic studies in environmental healthmay represent a good way of highlighting new 
biomarkers linked with pollutant exposures and suggesting hypotheses for a better 
understanding ofthe mechanistic pathways associated with metabolic changes. This short 
review allows identification of some issues in order to come up with an ideal design from an 
environmental health perspective: this ideal design should be as similar as possible to an 
experimental situation where the only modifying factor would be environmental exposure, i.e. 
without confounding factors. Both toxicology and epidemiology have advantages and 
limitations. In toxicology,the controlled conditions of very simple mixtures limit variability 
and confusion factors - but the difficulty lies in getting closer to the real human exposures 
(number of pollutants and levels of exposure). Epidemiology allows the complexity of human 
exposures to be taken into account yet requires the definition of strategies aimed at reducing 
the number of confoundingfactors. These observations involvethe development of new 
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original environmental health strategies that combine both human and animalstudies. The 
main challenges in study design, recruitment of individuals or definition of exposure groups, 
sampling strategy, statistical tools used, pathway analysis and system biology are briefly 
described below. 
Study design, recruitment of individuals and definition of exposure groups 
The use of metabolomics in environmental epidemiology requires an 
improvementinexperimental protocols to optimizereliability, reproducibility, and sensitivity. 
One solutionis the use of large-scale studies such as metabolome-wide association studiesor 
metabolic phenotyping for which optimal protocols (sampling strategies, analyses and 
processing) have been largely described elsewhere (Bictash et al. 2010;Dumas et al. 
2006).The interest of these studies mainly lies in the possibility of studying both phenotypic 
and cultural/environmental factors (especially diet). At this scale, it is possible to link 
metabolic profiling with the presence of risk factors or disease. For example, in the study 
from Holmes et al. (Holmes et al. 2008), cultural differences and diet could be considered as a 
surrogate for environmental differences, without acknowledgment of direct contaminant 
exposures. The same issues could be expressed for environmental epidemiology on a smaller 
scale. Furthermore, in this case, three main challenges may be described: 
Limitation of the inter and intra-individual variability within groups being compared: the 
population studied should be sufficiently homogeneous to reduce uncontrolled variability, 
especially in terms of diet. This could be achieved through the choice of culturally-similar 
individuals (Lenz et al. 2004) having the same gender, age and physiological conditions – 
such asbody mass index, for example – and without specific pathologies or medication. 
Limitation of co-exposure and other confounding factors: this could be achieved by making 
all co-variables – such as diet (the most important co-variable in environmental health) – 
homogeneous, for example by choosing culturally-similar individuals. In addition, it is 
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advisedthat the number of individuals be high enough to take into account non-controllable 
variability. But giving a minimal number of subjects is almost impossible in metabolomics 
because of poor knowledge of variability of endogenous metabolites in all biological fluids, 
cells or tissues. 
The choice of a contrasted environmental exposure between groups of individuals: in this 
case, in environmental epidemiology, geographical indicators may be used as a surrogate for 
complex and multiple exposures, since some studies have shown that residential proximity to 
anthropic activities could increase exposure to pollutants. This is well established with 
pesticides exposure and agricultural area, as shown by several authors (Jamin et al. 2013; 
Munoz-Quezada et al. 2012; Gunier et al. 2011; Bradman et al. 2011). But the measurement 
of environmental exposures remains a challenge. Exposure should be assessed in different 
ways, associating, for example, biological measurements with geographical indicators.In 
toxicology, the challenge remains in the definition of exposures as similar as possible to 
human exposures, taking into account their complexity in terms of both number of pollutants 
and choice of dose levels. Few toxicological studies are designed using these hypotheses 
(Cabaton et al. 2013; Zhang Y. et al. 2011; Mehri et al. 2010). 
Biological sampling strategy 
Type of biological fluid and sampling and storage conditions are essential to the design of 
sampling strategy(Alvarez-Sanchez et al. 2010b). Blood and urine metabolic profiles are now 
preferred over other biological fluids because they embody a large number of metabolic 
pathways representative of the whole metabolism of an organism. Theyare better studied. 
Other biological fluids such as saliva or hair are becoming emerging media, due to the non-
invasiveness of their sampling procedures (Zhang et al. 2012; Bessonneau et al. 2013; 
Neyraud et al. 2013). The moment of collection for each individual should be as similar as 
possible since there is considerable intra-individual variability depending on time of day or 
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night, especially for urine. Finally, storage conditions must be closely controlled to avoid 
microbial contamination or degradation, and should be the same as for all samples analyzed in 
orderto reduce inter-individual variability.Few studies have directly discussed storage 
conditions for metabolomics use. Most of these showed low metabolic degradation where 
samples are frozen immediately, or at most 24 hours followingcollection at ambient 
temperature (Maher et al. 2007). This was confirmed by Peakman and Elliott (2008) who 
tested sample stability at 4°C and 18°C in different studies, and showed integrity of the 
samples maintained at 4°C at least up to 24 hours (Peakman and Elliott, 2008). Dunn et al. 
(2008) also showed that analytical variance was of the same magnitude as variance observed 
between samples stored at 4°C for 0 or 24 hours (no statistical significant changes between 
the 2 storage conditions) (Dunn et al. 2008). Likewise, a long period of freezing (-40° C for 
urine and -80° C for blood, for 9 months) does not appearto have any impact on the metabolic 
profile (Beckonert, 2007). Recently, Hebels et al. studied the influence of long-term storage of 
blood samples for omics analysis in environmental health research. No trend was observed in 
relation to the storage temperature after immediate thawing (storage at -80°C from several 
weeks to several months) (Hebels et al. 2013).Although one study showed minimal effects of 
storage temperature (overa period of one week) on human plasma lipids profiles (tested 
conditions: 4°C, -20°C and -80°C) (Zivkovic et al. 2009), Deprez et al. showed more changes 
following storage at 4°C or at room temperature on rat plasma samples. The changes observed 
could be due to lipid hydrolysis (Deprez et al. 2002). However, even though a few studies 
showed significant modifications of metabolic profiles in plasma, in order to define the most 
rigorous study design, it would be preferable to have immediate freezing of biological 
samples, directly after collection, to prevent changes and decrease possible variability 
observed between samples.  
Analytical methods 
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In terms of their advantages and limitations, both NMR and MS techniques appear to be 
highly complementary.On the one side, the ease of sample preparation and rapid analysis time 
provided by NMR techniques is well adapted to high throughput fingerprinting, and on the 
other, the high sensitivity of MS techniques and their ability to measure more metabolites 
allows for extended metabolome coverage. Indeed, NMR allows for the measurement of 
major metabolites (i.e. metabolites in the field of micromolar concentrations) such as amino 
acids, organic acids, carbohydrates and lipids. MS is able to evidence minor metabolites such 
as steroids, hormones, neurotransmitters or other trace compounds, which may be present at 
concentrations as low as picomolar. On the other hand, NMR provides access to highly polar 
metabolites (sugars, sugar phosphates, etc) which are often difficult to handle using the 
universal reversed phase C18-based LC-MS methods, and which may require specific 
analytical strategies such as hydrophilic (ion) interaction liquid chromatography (HILIC) – 
MS or capillary electrophoresis – MS coupling (Idborg et al. 2005; Cubbon et al. 2010; 
Ramautar et al. 2013). It therefore appear relevant, in order to identify dynamic pathways of 
toxicity, to associate the two technologies in metabolomics for environmental health. As 
discussed by Bouhifd et al., the choice of an analytical tool is generally a compromise 
between sensitivity and selectivity (Bouhifd et al. 2013). However, the combined use of NMR 
and MS could enable characterization of many more metabolites – not only those related to 
the functioning of the organism (endogenous metabolites), but also those generated by 
environmental exposure (traces of pollutants). Indeed, in addition to the identification of 
endogenous metabolites, metabolomics is already used in the detection and identification of 
metabolites coming from xenobiotics, using targeted or semi-targeted techniques. For 
example, conjugated metabolites of bisphenol A were unambiguously characterizedin plasma, 
urine and testis from laboratory rodents orally exposed (Lacroix et al. 2011; Chen et al. 2012) 
using targeted profiling.Semi-targeted profiling was used to characterize pesticide metabolites 
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in the urine of pregnant women living in a French agricultural area. Based on a list of 
numerous pesticides commonly used on French crops, and using UHPLC coupled to HRMS, 
several metabolites from two fongicides (azoxystrobin and fenpropimorph) were identified in 
the urine of thosewomen livingin areas where cereal cropspredominate(Jamin et al. 2013). 
This approach can be considered to bea first step in the characterization of an “exposome”, 
since it was described for the first time by Wild (2005) and defined as the totality of all 
exposure over a lifetime. The term “all exposure” refers to a global approach taking into 
account not only a variety of sources such as hazardous agents (chemical, physical, 
biological) as well as social characteristics considered “external exposures” – but also all 
measurable biomarkers (metabolites, adducts, biotransformation products, etc.) considered as 
markers of “internal exposures”. Rappaport defined two generic approaches for characterizing 
the exposome: the bottom-up approach characterizing external exposure (environmental 
contamination and exposure assessment), which is useful in improving prevention strategies 
in public health, and the top-down approach, which uses untargeted omics techniquesto 
identify biomarkers in biological fluids, and is useful inimproving knowledge about the 
causes of human disease (Lioy and Rappaport, 2011; Rappaport, 2011).In characterizing the 
global exposure of human populations at different stages of life, metabolomics could make 
the connection between “external” and “internal” exposures at critical periods of life, as it was 
described by T.J. Athersuch (Athersuch, 2012).This author and his collaborators proposed 
several keys to the development and application of omics technologies (including 
metabolomics) in environmental epidemiology (Vineis et al. 2013). 
Statistical analysis 
In environmental epidemiology, supervised methods could be preferred due to the high level 
of variability within a human population, often inducing a lack of separation with 
unsupervised methods such as PCA (Miller, 2007). For example, cluster analysis and PLS 
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have been already shown to be successful in human studies (Ellis et al. 2012;Bonvallot et al. 
2013; Holmes et al. 2008). However,application of a preliminary PCA would be 
usefulinhighlighting the spontaneous separation of outliers. 
Biomarker identification 
Currently, metabolite identification remains a key challenge in metabolomics. Even though 
(as previously mentioned) numerous databases have been established and developed in recent 
years, none of these offers overall coverage of the metabolome. Searching against all 
databases is necessary, but comparison of information from one database to another is 
difficult, due to the varying data format or data recovery methods used. To improve the 
biomarker identification step, many bio-informatics toolshave been developed, covering both 
MS (Zhou et al. 2012; Li et al. 2013) and NMR spectra (Tulpan et al. 2011). 
Biological interpretation 
Acquisition of information – on the quantities of the different metabolites found in biological 
fluids in normal conditions, and factors influencing their levels in biological fluids in order to 
be able to detect subtle disturbances related to environmental factors – is an important 
challenge(Vlaanderen et al. 2010). Many studies have been published concerning the impact 
of certain physiological parameters in the metabolic profiles of a normal healthy population. 
The main factors include, but are not limited to: age (D'Adamo et al. 2010;Gu et al. 2009), 
gender (Bertram et al. 2009;Kochhar et al. 2006), body mass index (Bertram et al. 2009) and 
also diet ingested 24 hours prior to collection(Lenz et al. 2004). These studies are very helpful 
in improving knowledge about metabolic variability between healthy individuals, and could 
be very useful in environmental epidemiology. Additional mechanistic information onthe 
metabolic pathways involved in the toxicity of complex mixtures should be 
providedfromanimal experiments. Indeed, the use of environmental health metabolomics in 
humans is still exploratory and it requires the creation of a connection between metabolic 
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modifications which may be observed, early toxicity and adverse effects on the organism, as 
made by Ellis et al. with the association between modified urinary metabolic profiles and 
proteinuria (Ellis et al. 2012). These connections are easier to determine in animals with the 
use of different doses scales, allowing to identify adverse effects, early toxic effects, and 
metabolic changes in a same experiment. In this case, given the great diversity of 
environmental exposures, the challengeslie in the choice of exposure groups and model 
chemical mixtures that are as close as possible to human exposure andin finding out how the 
various metabolites are connected together in order to regulate cell functioning. The question 
that needs to be addressed is: what is the biological and health significance in the whole 
organism of the observed metabolic changes? 
The understanding of biological networks is of great interest but still needs significant 
development, particularlyin computational tools (Kholodenko et al. 2012). Progress has been 
made recently in the reconstruction of the metabolic networks of biological systems, and the 
mechanisms triggering the shifts of these metabolic networks following exposure to model 
contaminants. For this, NMR was used, but also high-resolution MS, which grants access to a 
larger set of metabolites, and makes it possible to characterize their exact mass. In order to 
study the modulation of metabolic networks and to gain a better understanding of the 
mechanisms of action of low doses of contaminants, computational models of these networks 
have been developed (Jourdan et al., 2010). In parallel, there has been considerable progress 
in the development of bioinformatic tools and databases (e.g. KEGG (Kanehisa and Goto, 
2000) and HMDB (Wishart et al. 2007, 2009, 2013)) making metabolomics studies much 
more quantitative and far more extensive in terms of metabolic coverage. Recent biochemical 
databases provide information about the interconnectivity of metabolism which can be 
automatically polled using metabolomics secondary analysis tools. Starting with lists of 
altered metabolites, there are two main types of analysis: enrichment analysis computes which 
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metabolic pathways have been significantly altered whereas metabolite mapping 
contextualizes the abundances and significances of measured metabolites into network 
visualizations (Booth et al. 2013). 
In this case, targeted metabolomics on particular metabolic pathways could be an interesting 
perspective in order to explain more in-depth environmental contaminant mechanisms of 
action. 
Finally, this short review has shown that although numerous studies are published in the field 
of toxicology to study the mechanisms of action of environmental pollutants, little 
epidemiological data gives rise to a comprehensive knowledge of what may be observed in 
humans. The issue of animal-to-human extrapolation – well-studied in hazard 
characterization– is still topical, and remains a challenge in metabolomics. A new research 
strategy is needed in order to understand the significance of the modifications observed in a 
metabolic profile as well as the validity of the biomarkers identified in toxicology. The role of 
in vitro metabolomics may have the capacity to meet this challenge with the development of 
human cell assays and the comparison of the mechanisms of action of environmental 
pollutants between species. 
 
In conclusion, metabolomics may be a powerful tool in environmental health for two main 
reasons: 1) the identification of complex exposure biomarkers, directly in human populations, 
or the characterization of “internal exposures” as an approximation of the exposome; and 2) 
the identification of modified metabolic pathways allowing the suggestion of hypotheses on 
mechanisms of toxicity and in order to better understand the environmental causes of 
diseases. Although it is not yet well used in humans, there is potential for the development of 
this technique, associated with classical environmental epidemiology and toxicology, as was 
shown by the first studies published in this field in recent years.Numerous key challenges 
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were highlighted that needed further research – including recruitment of individuals and 
definition of exposure groups, sampling strategies, analytical and statistical techniques, 
metabolite identification and biological/ toxicological interpretation. In addition, the relevance 
of animal-to-human extrapolation remains a dominant issue. 
 
References 
Aliferis K.A. and M. Chrysayi-Tokousbalides. 2011. Metabolomics in pesticide research and 
development: review and future perspectives. Metabolomics 7(4):35-53. 
Alvarez-Sanchez B., F. Priego-Capote, and M. Luque de Castro. 2010a. Metabolomics 
analysis II. Preparation of biological samples prior to detection. TrAC Trends Anal Chem 29: 
120-127. 
Alvarez-Sanchez B., F. Priego-Capote, and M. Luque de Castro. 2010b. Metabolomics 
analysis I. Selection of biological samples and practical aspects preceding sample preparation. 
TrAC Trends Anal Chem 29: 111-119. 
Athersuch T.J. 2012. The role of metabolomics in characterizing the human exposome. 
Bioanalysis 4(18):2207-2212. 
Bair E., T. Hastie, D. Paul, and R. Tibshirani. 2006. Prediction by Supervised Principal 
Components. JASA 101: 119-137. 
Bedair M. and L.W. Sumner. 2008. Current and emerging mass-spectrometry technologies for 
metabolomics. TrAC Trends Anal Chem 27: 238-250. 
Beger R.D., J. Sun, and L.K. Schnackenberg. 2010. Metabolomics approaches for discovering 
biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243: 
154-166. 
Bertram H.C., J.O. Duus, B.O. Petersen, C. Hoppe,A. Larnkjaer, L. Schack-Nielsen, C. 
Molgaard,and K. Michaelsen. 2009. Nuclear magnetic resonance-based metabonomics reveals 
28 
 
strong sex effect on plasma metabolism in 17-year-old Scandinavians and correlation to 
retrospective infant plasma parameters. Metabolism 58: 1039-1045. 
Bessonneau V., B. Bojko, and J. Pawliszyn. 2013. Analysis of human saliva metabolome by 
direct immersion solid-phase microextraction LC and benchtop orbitrap MS. Bioanal 
5(7):783-792. 
Bictash M., T.M. Ebbels, Q. Chan, R.L. Loo, I.K.S. Yap, I.J. Brown, M. de Iorio, M.L. 
Daviglus, E. Holmes, J. Stamler, J.K. Nicholson, and P. Elliott. 2010. Opening up the "Black 
Box": Metabolic phenotyping and metabolome-wide association studies in epidemiology. J 
Clin Epidemiol 63: 970-979. 
Bonvallot N., M. Tremblay-Franco, C. Chevrier, C. Canlet, C. Warembourg, J-P Cravedi and 
S. Cordier.2013. Metabolomics Tools for Describing Complex Pesticide Exposure in Pregnant 
Women in Brittany (France). PLoS ONE 8(5): e64433. doi:10.1371/journal.pone.0064433. 
Booth S.C., A.M. Weljie, R.J. Turner. 2013. Computational Tools for the Secondary Analysis 
of Metabolomics Experiments. Comp and Struct Biot Journal 4(5):e201301003. 
Bothwell J.H.F. and J.L. Griffin. 2011. An introduction to biological nuclear magnetic 
resonance spectroscopy. Biological Reviews 86: 493-510. 
Bouhifd M., T. Hartung, H.T. Hogberg, A. Kleensang, and L. Zhao. 2013. Review: 
Toxicometabolomics. J Appl Toxicol. doi: 10.1002/jat.2874. 
Bradman A., R. Castorina, D. Boyd Barr, J. Chevrier, M.E. Harnly, E.A. Eisen, T.E. McKone, 
K. Harley, N. Holland and B. Eskenazi. 2011. Determinants of organophosphorus pesticide 
urinary metabolite levels in young children living in an agricultural community. Int J Environ 
Res Public Health 8: 1061-1083. 
Broadhurst D. and D.B. Kell. 2006. Statistical strategies for avoiding false discoveries in 
metabolomics and related experiments. Metabolomics 2: 171-196. 
29 
 
Cabaton N., C. Canlet, P.R. Wadia, M. Tremblay-Franco, R. Gautier, J. Molina, C. 
Sonnenschein, J-P. Cravedi, B.S. Rubin,A.M. Soto, D. Zalko. 2013. Effects of Low Doses of 
Bisphenol A on the Metabolome of Perinatally Exposed CD-1 Mice. Environ Health Perspect 
doi:10.1289/ehp.1205588. 
Canlet C., M. Tremblay-Franco, R. Gautier, J. Molina, B. Métais, F. Blas-Y-Estrada, L. 
Gamet-Payrastre. 2013. Specific Metabolic Fingerprint of a Dietary Exposure to very Low 
Dose of Endosulfan. J Toxicol 545802. http://dx.doi.org/10.1155/2013/545802 
Chen M., B. Xu, W. Ji, S. Qiao, N. Hu, Y. Hu, W. Wu,L. Qiu, R.  Zhang, S. Wang, Z. Zhou, 
Y. Xia, X. Wang. 2012. Bisphenol A alters n-6 fatty acid composition and decreases 
antioxidant enzyme levels in rat testes: a LC-QTOF-based metabolomics study. PLoS 
One7(9):e44754. 
Cubbon S., C. Antonio, J. Watson, J. Thomas-Oates. 2010. Metabolomic applications of 
HILIC-LC-MS. Mass Spectrom. Rev. 29: 671-684. 
D'Adamo P., S. Ulivi, A. Beneduci, G. Pontoni, G. Capasso, C. Lanzara, G. Andrighetto, U. 
Hladnik, V. Nunes, M. Palacin, and P. Gasparini. 2010. Metabonomics and population 
studies: age-related amino acids excretion and inferring networks through the study of urine 
samples in two Italian isolated populations. Amino Acids 38: 65-73. 
Demur C., Métais B., Canlet C., Tremblay-Franco M., Gautier R., Blas-Y-Estradas F., 
Sommer C., gamet-Payrastre L.  2013. Dietary exposure to a low dose of pesticides alone or 
as a mixture: the biological metabolic fingerprint and impact on hematopoiesis. Toxicology 
308:74-87. 
Deprez S., B.C. Sweatman, S.C. Connor, J.N. Haselden, and C.J. Waterfield. 2002. 
Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic 
analysis in toxicology studies to determine inherent variation in biochemical profiles. J Pharm 
Biomedical Analysis 30: 1297-1310. 
30 
 
Dettmer K., P.A. Aronov, and B.D. Hammock. 2007. Mass spectrometry-based 
metabolomics. Mass Spectrom Rev 26: 51-78. 
Diaz S.O., J. Pinto, G. Graça, I.F. Duarte, A.S. Barros, E. Galhano, C. Pita, M. Almeida, B.J. 
Goodfellow, I.M. Carreira, and A.M. Gil. 2011. Metabolic biomarkers of prenatal disorders: 
an exploratory NMR metabonomics study of 2nd trimester maternal urine and blood plasma. J 
Proteome Res 10: 3732-3742. 
Du L., H. Wang, W. Xu, Y. Zeng, Y. Hou, Y. Zhang, X. Zhao,and C. Sun. 2013. Application 
of Ultraperformance Liquid Chromatography/Mass Spectrometry-Based Metabonomic 
Techniques to Analyze the Joint Toxic Action of Long-term Low-Level Exposure to a 
Mixture of Organophosphate Pesticides on Rat Urine Profile. Toxicol Sciences. doi: 
10.1093/toxsci/kft091. 
Duarte N.C., S.A. Becker, N. Jamshidi, I. Thiele, M.L. Mo, T.D. Vo, R. Srivas, and B.O. 
Palsson. 2007. Global reconstruction of the human metabolic network based on genomic and 
bibliomic data. Proceedings of the National Academy of Sciences of the United States of 
America, 104(6): 1777-1782. 
Dumas M.E., E.C. Maibaum, C. Teague, H. Ueshima, B. Zhou, J.C. Lindon, J.K. Nicholson, 
J. Stamler, P. Elliott, Q. Chan,and E. Holmes. 2006. Assessment of analytical reproducibility 
of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the 
INTERMAP Study. Anal Chem 78: 2199-2208. 
Dunn W.B., N.J.C. Bailey, and H.E. Johnson. 2005. Measuring the metabolome: current 
analytical technologies. Analyst 130: 606-625. 
Dunn W.B., D. Broadhurst, D.I. Ellis, M. Brown, A. Halsall, S. O'Hagan, I. Spasic, A. Tseng 
and D.B. Kell. 2008. A GC-TOF-MS study of the stability of serum and urine metabolomes 
during the UK Biobank sample collection and preparation protocols. International Journal Of 
Epidemiology 37 Suppl 1: i23-i30. 
31 
 
Ellis J., T. Athersuch, L. Thomas, F. Teichert, M. Perez-Trujillo,C. Svendsen, D. Spurgeon,R. 
Singh,L. Jarup,J. Bundy, and H. Keun. 2012. Metabolic profiling detects early effects of 
environmental and lifestyle exposure to cadmium in a human population. BMC Medicine 10: 
61. 
Eveillard A., F. Lasserre, M. de Tayrac, A. Polizzi, S. Claus, C. Canlet, L. Mselli-Lakhal, G. 
Gotardi, A. Paris, H. Guillou, P.G.P. Martin, and T. Pineau. 2009. Identification of potential 
mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP) adult exposure in the liver 
using a systems biology approach. Toxicol Appl Pharmacol 236: 282-292. 
Feng Z., X. Sun, J. Yang, D. Hao, L. Du, H. Wang, W. Xu, X. Zhao, and C. Sun. 2012. 
Metabonomics analysis of urine and plasma from rats given long-term and low-dose 
dimethoate by ultra-performance liquid chromatography-mass spectrometry. Chemico-
Biological Interactions 199: 143-153. 
Fiehn O. 2002. Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 
48: 151-171. 
Fukushima A. andM. Kusano. 2013. Recent progress in the development of 
metabolomedatabases for plant systems biology.Front Plant Sci. 4:73. doi: 
10.3389/fpls.2013.00073. 
Gu H., Z. Pan, B. Xi, B.E. Hainline, N. Shanaiah, V. Asiago,G.A.N. Gowda, and D. Raftery. 
2009. 1H NMR metabolomics study of age profiling in children. NMR In Biomedicine 22: 
826-833. 
Gunier R.B., M.H. Ward, M. Airola,E.M. Bell, J. Colt, M. Nishioka, P.A. Buffler, P. 
Reynolds, R.P. Rull, A. Hertz, C. Metayer and J.R. Nuckols. 2011. Determinants of 
agricultural pesticide concentrations in carpet dust. Environ Health Perspect 119: 970-976. 
Hao DF, Xu W, Wang H, Du LF, Yang JD, Zhao XJ, Sun C.H. 2012. Metabolomic analysis 
of the toxic effect of chronic low-dose exposure to acephate on rats using ultra-performance 
32 
 
liquid chromatography/mass spectrometry. Ecotoxicology and Environmental Safety 83: 25-
33. 
Hebels D.G., P. Georgiadis, H.C. Keun,T.J. Athersuch, P. Vineis, R. Vermeulen, L. 
Portengen, I.A. Bergdahl, G. Hallmans, D. Palli, B. Bendinelli, V. Krogh, R. Tumino, C. 
Sacerdote, S. Panico, J.C.S. Kleinjans, T.M.C.M De Kok, M.T. Smith and S.A. Kyrtopoulos. 
2013. Performance in omics analyses of blood samples in long-term storage: opportunities for 
the exploitation of existing biobanks in environmental health research. Environ Health 
Perspect. 121:480-487. 
Holmes E., R.L. Loo, J. Stamler, M. Bictash, I.K. Yap, Q. Chan, T. Ebbels, M. de Iorio, I.J. 
Brown, K.A. Veselkov, M.L. Daviglus, H. Kesteloot, H. Ueshima, L. Zhao, J.K. Nicholson, 
and P. Elliott. 2008. Human metabolic phenotype diversity and its association with diet and 
blood pressure. Nature 453: 396-400. 
Idborg H., L. Zamani, P.O. Edlund, I. Schuppe-Koistinen, and S.P. Jacobsson. 2005. 
Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction 
liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 828: 9-
13.  
Jamin E., N. Bonvallot, M. Tremblay-Franco, J-P. Cravedi, C. Chevrier, S. Cordier, and L. 
Debrauwer. 2013. Untargeted profiling of pesticide metabolites by LC–HRMS: an 
exposomics tool for human exposure evaluation. Anal Bioanal Chem. DOI 10.1007/s00216-
013-7136-2. 
Jourdan F., L. Cottret, L. Huc, D. Wildridge, R. Scheltema, H. Hillenweck, M.P. Barrett, D.  
Zalko, D.G. Watson, and L. Debrauwer. 2010. Use of reconstituted metabolic networks to 
assist in metabolomic data visualization and mining. Metabolomics 6(2):312-321. 
Kanehisa M. and S. Goto. 2000. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic 
Acids Res 28:27-30. 
33 
 
Kenny L.C., D. Broadhurst, M. Brown, W.B. Dunn, C.W.G. Redman, D.B. Kell, and P.N. 
Baker. 2008. Detection and identification of novel metabolomic biomarkers in preeclampsia. 
Reprod Sci 15: 591-597. 
Kholodenko B., M.B. Yaffe, and W. Kolch. 2012. Computational approaches for analyzing 
information flow in biological networks. Sci Signal 5: 1-14. 
Kim K.B., S.H. Kim, S.Y. Um, M.W. Chung, J.S. Oh, S.C. Jung, T.S. Kim, H.J. Moon, S.Y. 
Han, H.Y. Oh, B.M. Lee, and K.H. Choi. 2009. Metabolomics approach to risk assessment: 
methoxyclor exposure in rats. J. Toxicol. Environ. Health A Cur. Issues. 72: 1352-1368. 
Kim K.B., J.Y. Yang, S.J Kwack, K.L. Park, H.S. Kim, D.H. Ryu, Y.J. Kim, G.S. Hwang and 
B.M. Lee. 2010. Toxicometabolomics of Urinary Biomarkers for Human Gastric Cancer in a 
Mouse Model. J. Toxicol. Environ. Health A Cur Issues. 73:1420-1430. 
Kochhar S., D.M. Jacobs, Z. Ramadan, F. Berruex, A. Fuerholz, and L.B. Fay. 2006. Probing 
gender-specific metabolism differences in humans by nuclear magnetic resonance-based 
metabonomics. Anal Biochem 352: 274-281. 
Koek M., R.H. Jellema, J. van der Greef, A.C. Tas, and T. Hankemeier. 2011. Quantitative 
metabolomics based on gas chromatography mass spectrometry: status and perspectives. 
Metabolomics 7: 307-328. 
Kuo C.H., K.C. Wang, T.F. Tian, M.H. Tsai, Y.M. Chiung, C.M. Hsiech, S.J. Tsai, S.Y. 
Wang, D.M. Tsai, C.C. Huang, and Y.J. Tseng. 2012. Metabolomic characterization of 
laborers exposed to welding fumes. Chem Res Toxicol 25: 676-686. 
Lacroix M.Z., S. Puel, S.H. Collet, T. Corbel, N. Picard-Hagen, P.L. Toutain, C. Viguié, V. 
Gayrard. 2011. Simultaneous quantification of bisphenol A and its glucuronide metabolite 
(BPA-G) in plasma and urine: applicability to toxicokinetic investigations.Talanta85(4):2053-
2059. 
34 
 
Lenz E.M., J. Bright, I.D. Wilson, A. Hughes, J. Morrisson, H. Lindberg, and A. Lockton. 
2004. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of 
urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal 36: 
841-849. 
Li L., R. Li, J. Zhou, A. Zuniga, A.E. Stanislaus, Y. Wu, T. Huan, J. Zhang, Y. Shi, D.S. 
Wishart and G. Lin. 2013. MyCompoundID: using evidence-based metabolome library for 
metabolite identification. Anal Chem 85(6):3401-3408. 
Liang Y.J., H.P. Wang, L. Yang, W. Li, and Y.J. Wu. 2012a. Metabonomic responses in rat 
urine following subacute exposure to propoxur. Int J Toxicol 31(3):287-293. 
Liang Y.J., H.P. Wang, D.X. Long, and Y.J. Wu. 2012b. (1)H NMR-based metabonomic 
profiling of rat serum and urine to characterize the subacute effects of carbamate insecticide 
propoxur. Biomarkers 17: 566-574. 
Liang Y.J., Wang H.P., Long D.X., Wu Y.J. 2012c. Applying biofluid metabonomic 
techniques to analyze the combined subchronic toxicity of propoxur and permethrin in rats. 
Bioanalysis 4: 2897-2907. 
Lindon J.C., E. Holmes, M.E. Bollard, E.G. Stanley, and J.K. Nicholson. 2004. 
Metabonomics technologies and their applications in physiological monitoring, drug safety 
assessment and disease diagnosis. Biomarkers 9: 1-31. 
Lindon J.C. and J.K. Nicholson. 2008. Analytical techniques for metabonomics and 
metabolomics, and multi-omic information recovery. TrAC Trends Anal Chem 27: 194-204. 
Lioy P.J. and S.M. Rappaport. Exposure Science and the Exposome: An Opportunity for 
Coherence in the Environmental Health Sciences. 2011. Environ Health Perspect 
109(11):A466-A467. 
Madsen R., T. Lundstedt, and J. Trygg. 2010. Chemometrics in metabolomics - a review in 
human disease diagnosis. Analytica Chimica Acta 659: 23-33. 
35 
 
Maher A.D., S.F. Zirah, E. Holmes, and J.K. Nicholson. 2007. Experimental and analytical 
variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. 
Anal Chem 79: 5204-5211. 
Mamas M., W. Dunn, L. Neyses, and R. Goodacre. 2011. The role of metabolites and 
metabolomics in clinically applicable biomarkers of disease. Archives of Toxicology 85: 5-
17. 
Merhi M., C. Demur, C. Racaud-Sultan, J. Bertrand, C. Canlet, F.B. Estrada, and L. Gamet-
Payrastre. 2010. Gender-linked haematopoietic and metabolic disturbances induced by a 
pesticide mixture administered at low dose to mice. Toxicology 267: 80-90. 
Miller M.G. 2007. Environmental metabolomics: a SWOT analysis (strengths, weaknesses, 
opportunities, and threats). J Proteome Res 6: 540-545. 
Molinska A., L. Blanchet, L.M.C. Buydens, S.S. Wijmenga. 2012. NMR and pattern 
recognition methods in metabolomics: from data acquisition to biomarker discovery: a 
review. Anal Chim Acta 750:82-97. 
Munoz-Quezada M.T., V. Iglesias, B. Lucero, K. Steenland, D.B. Barr, K. Levy, P.B. Ryan, 
S. Alvarado and C. Concha. 2012. Predictors of exposure to organophosphate pesticides in 
schoolchildren in the Province of Talca, Chile. Environ Int 47: 28-36. 
Neyraud E., M. Tremblay-Francon, S. Gregoire, O. Berdeaux and C. Canlet. 2013. 
Relationships between the metabolome and the fatty acidcomposition of human saliva; effects 
of stimulation. Metabolomics 9:213–222. 
Peakman T.C., Elliott P. 2008. The UK Biobank sample handling and storage validation 
studies. International Journal Of Epidemiology 37 Suppl 1: i2-i6. 
Putri S.P., Yamamoto S., Tsugawa H., Fukusaki E.  2013. Current metabolomics: 
Technological Advances. J Biosci Bioeng. http://dx.doi.org/10.1016/j.jbiosc.2013.01.004 
36 
 
Ramautar R., Somsen G.W., and de Jong G.J. 2013. CE-MS for metabolomics: developments 
and applications in the period 2010-2012. Electrophoresis 34: 86-98. 
Rappaport S.M. 2011. Implication of the exposome for exposure science. J Expo Sci Environ 
Epidemiol21(1):5-9. 
Robertson D.G., P.B. Watkins, and M.D. Reily. 2011. Metabolomics in Toxicology: 
Preclinical and Clinical Applications. Toxicol Sci 120: S146-70. 
Robertson D. 2005. Metabonomics in toxicology: A review. Toxicol Sci 85: 806-822. 
Ross A., G. Schlotterbeck, F. Dieterle, and H. Senn. 2007. NMR spectroscopy techniques for 
application to metabonomics. In: The handbook of metabonomics and metabolomics. Lindon 
JC, Nicholson JK, Holmes H (eds):55-112. 
Shintu L., R. Baudoin, V. Navratil, J-M. Prot, C. Pointoizeau, M. Defernez, B. Blaise, C. 
Domange, A.R. Péry, P. Toulhoat, C. Legallais, C. Brochot, E. Leclerc and M-E. Dumas. 
2012. Metabolomics-on-a-Chip and Predictive Systems Toxicology inMicrofluidic 
Bioartificial Organs. Anal. Chem. 84:1840−1848. 
Sumner S., Snyder R., Burgess J., Myers C., Tyl R., Sloan C., Fennell T. 2009. Metabolomics 
in the assessment of chemical-induced reproductive and developmental outcomes using non-
invasive biological fluids: application to the study of butylbenzyl phthalate. J Appl Toxicol 
29: 703-714. 
Sun X., Xu W, Zeng Y, Hou Y, Guo L, Zhao X, Sun C. 2012. Metabonomics evaluation of 
urine from rats administered with phorate under long-term and low-level exposure by ultra-
performance liquid chromatography-mass spectrometry. J Appl Toxicol. doi: 
10.1002/jat.2848 
Sun R., J. Zhang, M. Xiong, Y. Chen, L. Yin and Y. Pu. 2012. Metabolomics biomarkers for 
subacute toxicity screening for benzene exposure in mice. J Toxicol Environ health A 
75(18):1163-11-73. 
37 
 
Sun J., L. Schnackenberg, L. Pence, S. Bhattacharyya, D. Doerge, J. Bowyer and R. Beger. 
2010. Metabolomic analysis of urine from rats chronically dosed with acrylamide using NMR 
and LC/MS. Metabolomics 6(4):550-563. 
Theodoridis G.A., H.G. Gika, E.J. Want, and I.D. Wilson. 2012. Liquid chromatography-mass 
spectrometry based global metabolite profiling: A review. Anal Chim Acta 711: 7-16. 
Trygg J. and S. Wold. 2002. Orthogonal projections to latent structures. J Chemometrics 16: 
119-128. 
Tuplan D, S. Léger, L. Belliveau, A. Culf, and M. Čuperlović-Culf. 2011. MetaboHunter: an 
automatic approach for identification of metabolites from 1H-NMR spectra of complex 
mixtures. BMC Bioinfo 12:400. 
van den Berg R., Hoefsloot H., Westerhuis J., Smilde A., van der Werf M. 2006. Centering, 
scaling, and transformations: improving the biological information content of metabolomics 
data. BMC Genomics 7: 142 
van Ravenzwaay B., G. Coelho-Palermo Cunha, V. Strauss, J. Wiemer, E. Leibold, H. Kamp, 
T. Walk, W. Mellert, R. Looser, A. Prokoudine, E. Fabian, G. Krenrish, and M. Herold. 2010. 
The individual and combined metabolite profiles (metabolomics) of dibutylphthalate and di(2-
ethylhexyl)phthalate following a 28-day dietary exposure in rats. Tox Letters 198: 159-170. 
van Vliet E, S. Morath, C. Eskes, J. Linge, J. Rappsilber, P. Honegger, T. Hartung and S. 
Coecke. 2008. A novel in vitro metabolomics approach for neurotoxicity testing, proof of 
principle for methylmercury, mercury chloride and caffeine. Neurotoxicol 29(1):1-12. 
Vineis P., K. van Veldhoven, M. Chadeau-Hyam and T.J. Atersuch. 2013. Advancing the 
application of omics-based biomarkers in environmental epidemiology. Environ Mol 
Mutagen. doi: 10.1002/em.21764. 
38 
 
Vlaanderen J., L.E. Moore, M.T. Smith, Q. Lan, L. Zhang, C.F. Skibola, N. Rothman, and R. 
Vermeulen. 2010. Application of OMICS technologies in occupational and environmental 
health research; current status and projections. Occup Environ Med 67: 136-143. 
Vulimiri S.V., M. Misra, J.T. Hamm, M. Mitchell, and A. Berger. 2009. Effects of 
mainstream cigarette smoke on the global metabolome of human lung epithelial cells. Chem 
Res Toxicol 22(3):492-503. 
Wang H.P., Y.J. Liang, D.X. Long, J.X. Chen, W.Y. Hou, and Y.J. Wu. 2009. Metabolic 
profiles of serum from rats after subchronic exposutre to chlorpyrifos and carbaryl. Chem Res 
Toxicol 22(6):1026-1033. 
Wang H.P., Y.J. Liang, Q. Zhang, D.X. Long, W. Li, L. Li, L. Yang, X.Z. Yan, and Y.J. Wu. 
2011. Changes in metabolic profiles of urine from rats following chronic exposure to 
anticholinesterase pesticides. Pestic Biochem Physiol 101(3):232-239. 
Wang H.P., Y.J. Liang, Y.J. Sun, J.X. Chen, W.Y. Hou, D.X. Long, and Y.J. Wu. 2013. 1H 
NMR-based metabonomic analysis of the serum and urine of rats following subchronic 
exposure to dichlorvos, deltamethrin, or a combination of these two pesticides. Chemico-
Biological Interactions 203: 588-596. 
Waterman D.S., F.W. Bonner, and J.C. Lindon. 2009. Spectroscopic and statistical methods in 
metabonomics. Bioanalysis 1: 1559-1578. 
Werner E., J.F. Heilier, C. Ducruix, E. Ezan, C. Junot, and J.C. Tabet. 2008. Mass 
spectrometry for the identification of the discriminating signals from metabolomics: current 
status and future trends. J Chromatogr B 871: 143-163. 
Wild C.P. 2005. Complementing the genome with an "exposome": The outstanding challenge 
of environmental exposure measurement in molecular epidemiology. CEBP 14: 1847-1850. 
Wishart D.S., D. Tzur,C. Knox, R. Eisner, A.C. Guo, N. Young, D. Cheng, K. Jewell, D. 
Arndt, S. Sawhney, C. Fung, L. Nikolai, M. Lewis, M-A. Coutouly, I. Forsythe, P. Tang, S. 
39 
 
Shrivastava, K. Jeroncic, P. Stothard, G. Amegbey, D. Block, D.D. Hau, J. Wagner, J. 
Miniaci, M. Clements, M. Gebremedhin, N. Guo, Y. Zhang, G.E. Duggan, G.D. MacInnis, 
A.M. Weljie, R. Dowlatabadi, F. Bamforth, D. Clive, R. Greiner, L. Li, T. Marrie, B.D. 
Sykes, H.J. Vogel, and L. Querengesser. 2007. HMDB: The human metabolome database. 
Nucleic Acids Res 35: D521-D526. 
Wishart D.S., T. Jewison, A.C. Guo, M. Wilson, C. Knox, Y. Liu, Y. Djoumbou, R. Mandal, 
F. Aziat, E., S. Bouatra, I. Sinelnikov, D. Arndt, J. Xia, P. Liu, F. Yallou, T. Bjorndahl, R. 
Perez-Pineiro, R. Eisner, F. Allen, V. Neveu, R. Greiner, andA. Scalbert. 2013. HMDB 3.0 – 
The Human Metabolome Database in 2013.Nucleic Acids Res. 41:D801-7. doi: 
10.1093/nar/gks1065. 
Wishart D.S., C. Knox, A.C.Guo, R. Eisner, N. Young, B. Gautam, D.D. Hau, N. Psychogios, 
E. Dong, S. Bouatra, R. Mandal, I. Sinelnikov, J; Xia, L. Jia, J.A. Cruz, E. Lim, C.A. Sobsey, 
S. Shrivastava, P. Huang, P. Liu, L. Fang, J. Peng, R. Fradette, D. Cheng, D. Tzur, M. 
Clements, A. Lewis, A. De Souza, A. Zuniga, M. Dawe, Y. Xiong, D. Clive, R. Greiner, A. 
Nazyrova, R. Shaykhutdinov, L. Li, H.J. Vogel and I. Forsythe. 2009. HMDB: a 
knowledgebase for the human metabolome. Nucleic Acids Res. 37: D603–D610. doi:  
10.1093/nar/gkn810. 
Wold S., M. Sjostrom, and L. Eriksson. 2001. PLS-regression: a basic tool of chemometrics. 
Chem Intel Lab Syst 58: 109-130. 
Xia H.F., Y. Chi, X. Qi, M.M. Su, Y. Cao, P.P. Song, X. Li, T.L. Chen, A.H. Zhao, Y.N. 
Zhang, Y. Cao, X. Ma, and W. Jia. 2011. Metabolomic evaluation of di-n-butyl phthalate-
induced teratogenesis in mice. Metabolomics 7(4):559-571. 
Zhang A., H. Sun and X. Wang. 2012. Saliva metabolomics opens door to biomarker 
discovery, disease diagnosis, and treatment.Appl Biochem Biotechnol. 168(6):1718-1727. 
40 
 
Xu Y., S. Agrawal, T.J. Cook, and G.T. Knipp. 2007. Di-(2-ethylhexyl)-phthalate affects lipid 
profiling in fetal rat brain upon maternal exposure. Arch Toxicol 81(1):57-62. 
Yang J., X. Sun, Z. Feng, D. Hao, M. Wang, X. Zhao, and C. Sun. 2011. Metabolomic 
analysis of the toxic effects of chronic exposure to low-level dichlorvos on rats using ultra-
performance liquid chromatography-mass spectrometry. Toxicol Letters 206: 306-313. 
Yang J. H Wang, W. Xu, D. Hao, L. Du, X. Zhao and C. Sun. 2013. Metabolomic analysis of 
rat plasma following chronic low-dose exposure to dichlorvos. Hum Exp Toxicol 32(2):196-
205. 
Zhang H., L. Ding, X. Fang, Z. Shi,Y. Zhang, H. Chen, X. Yan, and J. Dai. 2011. Biological 
responses to perfluorododecanoic acid exposure in rat kidneys as determined by integrated 
proteomic and metabonomic studies. PLoS ONE 6: e20862-1-11. 
Zhang Y., B. Wu, Z.Y. Zhang, and S.P. Cheng. 2011. A metabonomic analysis on health 
effects of drinking water on male mice (Mus musculus). J Hazard Mat 190: 515-519. 
Zhang J., L. Yan, M. Tian, Q. Huang, S. Peng, S. Dong, and H. Shen. 2012. The 
metabonomics of combined dietary exposure to phthalates and polychlorinated biphenyls in 
mice. J Pharm Biomed Anal 66: 287-297. 
Zhou B, J. Wang, and H.W. Ressom. 2012. MetaboSearch: tool for mass-based metabolite 
identification using multiple databases. PolsOne 7(6):e40096. 
Zivkovic A., M. Wiest, U. Nguyen, R. Davis, S. Watkins, andJ. German. 2009. Effects of 
sample handling and storage on quantitative lipid analysis in human serum. Metabolomics 5: 
507-516. 
  
41 
 
Figure Legends 
Figure 1: Diagram of the toxicity of a contaminant and the link with the metabolic fingerprint 
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Figure 2: flowchart of a metabolomics analyses 
 
